Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
DeltaNp63 Overexpression, Alone and in Combination with Other Biomarkers, Predicts the Development of Oral Cancer in Patients with Leukoplakia
Clinical Cancer Research, 09/29/09
Saintigny P et al. – DeltaNp63 overepression in OPL is associated with increased oral cancer risk. Together, ?Np63, podoplanin, and EIC may be used as biomarkers to identify OPL patients with substantially high oral cancer risk.
Related Articles
Current practice and feasibility in microlaryngeal surgery: microsurgical pressing excision technique
Current Opinion in Otolaryngology and Head & Neck Surgery, 11/13/09
Relevance Score: 80%
Today in Head and Neck...keeping you current
Receive free subspecialty "5-minute updates" via email
Biomarkers Predict p53 Gene Therapy Efficacy in Recurrent Squamous Cell Carcinoma of the Head and Neck
Clinical Cancer Research, 12/11/09
Pemphigus vulgaris antigen mRNA quantification for the staging of sentinel lymph nodes in head and neck cancer
British Journal of Cancer, 12/11/09
Human papillomavirus infection and squamous cell carcinoma of the conjunctiva
British Journal of Cancer, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


